Copyright medicaldialogues
Hyderabad: Dr Reddy's Labs has appointed Srinivas Mallavarapu as Head, Global Portfolio and Head, Business Development, North America."We welcome back Srinivas Mallavarapu to the Dr. Reddy’s family as Head, Global Portfolio and Head, Business Development, North America," Dr Reddy's shared in a post on Linkedin.With over 25 years of global experience, Srinivas brings deep expertise in portfolio strategy and business development. Srinivas Mallavarapu returns to Dr Reddy's Labs, after spending more than 9 years at Cipla, where he served as Executive Vice President - Global Portfolio & Business Development and Senior Vice President, Global Portfolio & Business Development.Prior to that, he worked at Dr. Reddy’s for over six years in various leadership roles. He began his career with Keane Software Solutions as a Project Executive."Thrilled to re-join Dr Reddy's and contribute to its mission of Good Health Can't wait. Excited to help expand access to innovative, affordable medicines for patients around the world," Srinivas Mallavarapu said in a statement.Established in 1984, Dr. Reddy’s Laboratories Ltd. is a global pharmaceutical company headquartered in Hyderabad, India. The Company offers a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC. Its major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Dr Reddy's Labs major markets include – USA, India, Russia & CIS countries, China, Brazil and Europe.Read also: Dr Reddy's Labs assigns additional responsibilities of CHRO office to Sanjay Sharma
